fosamprenavir has been researched along with Pregnancy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duong, T; Ene, L; Galli, L; Giaquinto, C; Goetghebuer, T; Judd, A; Noguera Julian, A; Pimenta, JM; Ramos Amador, JT; Thorne, C | 1 |
| Bermudez, A; Garb, J; Kronschnabel, D; Martorell, C; Oie, K; Theroux, E | 1 |
| Aberg, JA; Castor, D; Cespedes, MS; Ford, SL; Lee, D; Lou, Y; Pakes, GE | 1 |
1 trial(s) available for fosamprenavir and Pregnancy
| Article | Year |
|---|---|
Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy.
Topics: Adult; Area Under Curve; Carbamates; Disease Transmission, Infectious; Female; Fetal Blood; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Organophosphates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Sulfonamides; Young Adult | 2013 |
2 other study(ies) available for fosamprenavir and Pregnancy
| Article | Year |
|---|---|
Post-licensing safety of fosamprenavir in HIV-infected children in Europe.
Topics: Adolescent; Anti-HIV Agents; Carbamates; Child; Cohort Studies; Europe; Female; Follow-Up Studies; Furans; HIV Infections; Humans; Hypercholesterolemia; Male; Organophosphates; Pregnancy; Product Surveillance, Postmarketing; Retrospective Studies; Sulfonamides | 2014 |
Safety and efficacy of fosamprenavir in human immunodeficiency virus-infected pregnant women.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; Female; Furans; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Organophosphates; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Sulfonamides; Treatment Outcome | 2010 |